好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association between Early Morning Motor Symptoms and Nocturnal Sleep Disturbance in Patients with Parkinson[apos]s Disease (PD) [ndash] A Post Hoc Analysis of the Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER) Study
Movement Disorders
(-)
003
Authors/Disclosures
Todd J. Swick, MD, FAAN (Takeda Pharmaceuticals) Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has stock in Takeda Pharmaceuticals.
No disclosure on file
Florian Hatz, MD No disclosure on file
No disclosure on file
Kimberly Moran, PhD (UCB) No disclosure on file
No disclosure on file
Claudia Trenkwalder, MD (Center For Parkinsonism and Movement Disorders) Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Tara M. Dutta, MD (Wellspan) No disclosure on file